Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Spironolactone and Insulin Resistance in CHF
NCT00664222Phase 4Completed
- Sponsor
- Tottori University Hospital
- Start
- Jan 2004
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of spironolactone in chronic heart failure (CHF), sponsored by Tottori University Hospital. Started Jan 2004; status: completed.
02
Drugs
spironolactone
03
Conditions
chronic heart failure (CHF)
Beyond the preview
Go deeper on NCT00664222.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00664222.